American Journal of Respiratory and Critical Care Medicine

Cardiology

Sepsis tied to higher post-discharge mortality risk

(HealthDay)—Sepsis survivors have a substantially increased risk of all-cause mortality and major adverse cardiovascular events after discharge, according to a study published online Jan. 25 in the American Journal of Respiratory ...

Cardiology

Cisatracurium ups some ARDS outcomes versus vecuronium

(HealthDay)—Among patients with acute respiratory distress syndrome (ARDS), cisatracurium does not improve mortality versus vecuronium but is associated with improvements in other outcomes, according to a study published ...

Health

Shared decision-making should be encouraged in ICU

(HealthDay)—Shared decision-making should be implemented in the intensive care unit (ICU) as a collaborative process involving patients (or their surrogates) and clinicians, according to a policy statement published online ...

Diseases, Conditions, Syndromes

Number of COPD events over one year predicts rate of future events

(HealthDay)—The frequency of acute exacerbations of chronic obstructive pulmonary disease (AECOPDs) in a single year predicts the long-term rate of AECOPDs, according to a study recently published in the American Journal ...

Health

Menopause linked to accelerated decline in lung function

(HealthDay)—Menopause is associated with accelerated decline in lung function, according to a study published in the April 15 issue of the American Journal of Respiratory and Critical Care Medicine.

Medical research

A new test to measure the effectiveness of CF drugs

UNC School of Medicine researchers have developed a new laboratory model of the infection- and inflammation-plagued airways of cystic fibrosis (CF) patients. The model, described in the American Journal of Respiratory and ...

Medications

Three-drug combination reduces COPD patient mortality

Once-daily treatment of patients with chronic obstructive pulmonary disease (COPD) with an inhaler combining fluticasone furoate (FF), umeclidinium (UMEC) and vilanterol (VI) reduced all-cause mortality by 42 percent, according ...

page 33 from 40